Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.
Papadimitriou
G N
GN
Theleritis
C G
CG
Papageorgiou
C C
CC
Kalogeromitros
D
D
Syrigou
E
E
Gregoriou
S
S
Rabavilas
A D
AD
D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects*; D003511:Cyclohexanols / Q000008:administration & dosage* / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy*; D004338:Drug Combinations; D003875:Drug Eruptions / Q000209:etiology*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000009:adverse effects*; D009966:Orphenadrine / Q000008:administration & dosage / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D004338:Drug Combinations; D009125:Muscle Relaxants, Central; D009966:Orphenadrine; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride